HALO logo

Halozyme Therapeutics, Inc. (HALO) Total assets

annual total assets:

$2.16B+$430.61M(+24.84%)
December 31, 2024

Summary

  • As of today (September 5, 2025), HALO annual total assets is $2.16 billion, with the most recent change of +$430.61 million (+24.84%) on December 31, 2024.
  • During the last 3 years, HALO annual total assets has risen by +$1.06 billion (+95.93%).
  • HALO annual total assets is now at all-time high.

Performance

HALO Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

quarterly total assets:

$2.05B-$142.63M(-6.49%)
June 30, 2025

Summary

  • As of today (September 5, 2025), HALO quarterly total assets is $2.05 billion, with the most recent change of -$142.63 million (-6.49%) on June 30, 2025.
  • Over the past year, HALO quarterly total assets has increased by +$84.45 million (+4.29%).
  • HALO quarterly total assets is now -6.49% below its all-time high of $2.20 billion, reached on March 31, 2025.

Performance

HALO quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

HALO Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.8%+4.3%
3 y3 years+95.9%+15.3%
5 y5 years+282.4%+289.7%

HALO Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+95.9%-6.5%+20.9%
5 y5-yearat high+282.4%-6.5%+291.9%
alltimeall timeat high>+9999.0%-6.5%>+9999.0%

HALO Total assets History

DateAnnualQuarterly
Jun 2025
-
$2.05B(-6.5%)
Mar 2025
-
$2.20B(+1.5%)
Dec 2024
$2.16B(+24.8%)
$2.16B(+2.2%)
Sep 2024
-
$2.12B(+7.5%)
Jun 2024
-
$1.97B(+6.9%)
Mar 2024
-
$1.84B(+6.2%)
Dec 2023
$1.73B(-5.9%)
$1.73B(-8.4%)
Sep 2023
-
$1.89B(+4.5%)
Jun 2023
-
$1.81B(+6.5%)
Mar 2023
-
$1.70B(-7.7%)
Dec 2022
$1.84B(+66.7%)
$1.84B(-1.2%)
Sep 2022
-
$1.86B(+4.7%)
Jun 2022
-
$1.78B(+53.3%)
Mar 2022
-
$1.16B(+5.2%)
Dec 2021
$1.10B(+90.4%)
$1.10B(-6.8%)
Sep 2021
-
$1.19B(+15.6%)
Jun 2021
-
$1.03B(+6.1%)
Mar 2021
-
$966.58M(+66.7%)
Dec 2020
$579.92M(+2.5%)
$579.92M(+10.7%)
Sep 2020
-
$524.03M(-0.6%)
Jun 2020
-
$527.00M(+7.0%)
Mar 2020
-
$492.35M(-13.0%)
Dec 2019
$565.87M(+28.5%)
$565.87M(+52.8%)
Sep 2019
-
$370.36M(-11.4%)
Jun 2019
-
$417.83M(-2.6%)
Mar 2019
-
$429.11M(-2.5%)
Dec 2018
$440.25M(-15.3%)
$440.25M(-1.0%)
Sep 2018
-
$444.51M(-6.4%)
Jun 2018
-
$474.75M(-4.2%)
Mar 2018
-
$495.47M(-4.7%)
Dec 2017
$519.95M(+98.8%)
$519.95M(+45.6%)
Sep 2017
-
$357.15M(+3.6%)
Jun 2017
-
$344.79M(+52.0%)
Mar 2017
-
$226.77M(-13.3%)
Dec 2016
$261.51M(+43.9%)
$261.51M(-7.4%)
Sep 2016
-
$282.50M(-4.6%)
Jun 2016
-
$296.13M(-4.2%)
Mar 2016
-
$309.10M(+70.0%)
Dec 2015
$181.79M(+9.5%)
$181.79M(+14.5%)
Sep 2015
-
$158.73M(-8.8%)
Jun 2015
-
$174.05M(+9.4%)
Mar 2015
-
$159.13M(-4.1%)
Dec 2014
$165.98M(+63.1%)
$165.98M(+0.8%)
Sep 2014
-
$164.63M(-9.6%)
Jun 2014
-
$182.05M(-7.9%)
Mar 2014
-
$197.69M(+94.2%)
Dec 2013
$101.79M
$101.79M(-7.6%)
DateAnnualQuarterly
Sep 2013
-
$110.15M(+2.6%)
Jun 2013
-
$107.39M(-8.1%)
Mar 2013
-
$116.87M(-13.3%)
Dec 2012
$134.73M(+104.9%)
$134.73M(+24.8%)
Sep 2012
-
$107.98M(-11.3%)
Jun 2012
-
$121.75M(-9.6%)
Mar 2012
-
$134.72M(+104.9%)
Dec 2011
$65.76M(-28.0%)
$65.76M(-16.0%)
Sep 2011
-
$78.24M(-12.6%)
Jun 2011
-
$89.51M(+10.6%)
Mar 2011
-
$80.93M(-11.4%)
Dec 2010
$91.35M(+18.4%)
$91.35M(-9.0%)
Sep 2010
-
$100.39M(+95.0%)
Jun 2010
-
$51.49M(-21.0%)
Mar 2010
-
$65.16M(-15.5%)
Dec 2009
$77.15M(+0.8%)
$77.15M(-10.4%)
Sep 2009
-
$86.11M(-10.6%)
Jun 2009
-
$96.30M(+39.7%)
Mar 2009
-
$68.93M(-10.0%)
Dec 2008
$76.56M(-26.0%)
$76.56M(-5.2%)
Sep 2008
-
$80.75M(-8.8%)
Jun 2008
-
$88.56M(-10.4%)
Mar 2008
-
$98.87M(-4.4%)
Dec 2007
$103.46M(+124.5%)
$103.46M(-5.9%)
Sep 2007
-
$109.99M(+5.6%)
Jun 2007
-
$104.13M(+41.0%)
Mar 2007
-
$73.87M(+60.3%)
Dec 2006
$46.09M(+124.7%)
$46.09M(+158.8%)
Sep 2006
-
$17.81M(+5.8%)
Jun 2006
-
$16.84M(-11.2%)
Mar 2006
-
$18.97M(-7.5%)
Dec 2005
$20.51M(+25.0%)
$20.51M(+177.7%)
Sep 2005
-
$7.39M(-32.5%)
Jun 2005
-
$10.94M(-21.2%)
Mar 2005
-
$13.88M(-15.4%)
Dec 2004
$16.40M(>+9900.0%)
$16.40M(+333.4%)
Sep 2004
-
$3.79M(-39.0%)
Jun 2004
-
$6.21M(-19.7%)
Mar 2004
-
$7.73M(>+9900.0%)
Dec 2003
$47.50K(-51.1%)
$47.50K(-30.2%)
Sep 2003
-
$68.10K(-11.6%)
Jun 2003
-
$77.00K(-16.3%)
Mar 2003
-
$92.00K(-5.3%)
Dec 2002
$97.20K(+272.4%)
$97.20K(-28.9%)
Sep 2002
-
$136.80K(-7.3%)
Jun 2002
-
$147.50K(+289.2%)
Mar 2002
-
$37.90K
Dec 2001
$26.10K
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual total assets?
  • What is the all time high annual total assets for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual total assets year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly total assets?
  • What is the all time high quarterly total assets for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly total assets year-on-year change?

What is Halozyme Therapeutics, Inc. annual total assets?

The current annual total assets of HALO is $2.16B

What is the all time high annual total assets for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual total assets is $2.16B

What is Halozyme Therapeutics, Inc. annual total assets year-on-year change?

Over the past year, HALO annual total assets has changed by +$430.61M (+24.84%)

What is Halozyme Therapeutics, Inc. quarterly total assets?

The current quarterly total assets of HALO is $2.05B

What is the all time high quarterly total assets for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly total assets is $2.20B

What is Halozyme Therapeutics, Inc. quarterly total assets year-on-year change?

Over the past year, HALO quarterly total assets has changed by +$84.45M (+4.29%)
On this page